NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 22 filers reported holding NEURODERM LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $39,000 | +85.7% | 996 | +42.3% | 0.00% | – |
Q2 2017 | $21,000 | +10.5% | 700 | 0.0% | 0.00% | – |
Q1 2017 | $19,000 | +18.8% | 700 | 0.0% | 0.00% | – |
Q4 2016 | $16,000 | +23.1% | 700 | 0.0% | 0.00% | – |
Q3 2016 | $13,000 | +18.2% | 700 | 0.0% | 0.00% | – |
Q2 2016 | $11,000 | +10.0% | 700 | 0.0% | 0.00% | – |
Q1 2016 | $10,000 | -93.3% | 700 | -92.0% | 0.00% | – |
Q4 2015 | $149,000 | +964.3% | 8,736 | +1148.0% | 0.00% | – |
Q3 2015 | $14,000 | -33.3% | 700 | -48.8% | 0.00% | – |
Q2 2015 | $21,000 | – | 1,368 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 826,799 | $11,674,000 | 6.53% |
Foresite Capital Management III, LLC | 292,371 | $4,128,000 | 3.19% |
Avoro Capital Advisors LLC | 537,477 | $7,589,000 | 2.65% |
Redmile Group, LLC | 1,180,887 | $16,674,000 | 1.71% |
NEXTHERA CAPITAL LP | 70,000 | $988,000 | 1.02% |
SCOPIA CAPITAL MANAGEMENT LP | 3,383,359 | $47,773,000 | 0.89% |
Foresite Capital Management II, LLC | 119,781 | $1,691,000 | 0.83% |
SENZAR ASSET MANAGEMENT, LLC | 215,400 | $3,041,448,000 | 0.60% |
SPHERA FUNDS MANAGEMENT LTD. | 166,359 | $2,349,000 | 0.51% |
Opaleye Management Inc. | 38,500 | $544,000 | 0.34% |